What is it about?

In this brief commentary we analyze using literature review, cardiac tamponade as a result of pericardial effusion in systemic lupus erythematosus (SLE). Potential predictors of tamponade in SLE can be of great value to physicians.

Featured Image

Why is it important?

Pericarditis is one of the most common manifestations of systemic lupus erythematosus (SLE). Its prevalence in these patients is reported as between 12 and 48% [1]. Fortunately, cardiac tamponade is a much less common sequel, with an incidence of less than 3% [1,2]. However on occasion an acutely ill patient does present with this complication, which is sometimes the initial manifestation of SLE as recently described by Tian et al. [3] in a young female. This presentation is not a new phenomenon — for instance Schoenfeld et al. [4] described a case more than half a century ago when the diagnosis of tamponade was on clinical grounds, prior to the advent of echocardiography.

Read the Original

This page is a summary of: Pericardial effusions in systemic lupus erythematosus — Who is most likely to develop tamponade?, International Journal of Cardiology, February 2015, Elsevier,
DOI: 10.1016/j.ijcard.2014.11.191.
You can read the full text:

Read

Contributors

The following have contributed to this page